Webinar: Comply with Weighing-Related Regulations in Pharma Manufacturing

Webinar: Comply with Weighing-Related Regulations in Pharma Manufacturing
Greifensee, Switzerland (PRWEB) April 06, 2015 Weighing applications in pharmaceutical manufacturing have a strong influence on the quality of the final product. However, while the pharmaceutical industry is one of the most regulated, regulatory frameworks such as Good Manufacturing Practices (GMP) usually provide only broad guidance. It is the responsibility of the manufacturer to interpret ...

World Peptide Therapeutics Marketplace Discussed by PNS Pharma in New Research Study Published at MarketPublishers.com

World Peptide Therapeutics Marketplace Discussed by PNS Pharma in New Research Study Published at MarketPublishers.com
London, UK (PRWEB) February 24, 2015 The use of peptides for treating a number of disease indications have been proved by researchers and some of them are currently available in the market. Peptide based therapeutics are frequently used in drug development programmes to offer greater pharmacological effects and help alleviate the medical symptoms and ...

Genedata Announces Strong Adoption of High Content Screening in Pharma R&D Running Genedata Screener

San Diego, Calif (PRWEB) January 26, 2015 Genedata, a leading provider of advanced software solutions for drug discovery and life science research, today announced that 75% of pharmaceutical companies running Genedata Screener® have adopted Genedata Screener for HCS for their phenotypic screening and other image-based screening projects. Extending the Genedata Screener platform, Genedata Screener for ...

Frontier Pharma – NSCLC – Identifying And Commercializing First-In-Class Innovation In Non-Small-Cell Lung Carcinoma – Available online at MarketResearchReports.Biz

Frontier Pharma - NSCLC - Identifying And Commercializing First-In-Class Innovation In Non-Small-Cell Lung Carcinoma - Available online at MarketResearchReports.Biz
ALBANY, New York (PRWEB) December 01, 2014 Marketresearchreports.biz has included a new market research report titled “Frontier Pharma – NSCLC – Identifying and Commercializing First-in-Class Innovation in Non-Small-Cell Lung Carcinoma” to its extensive collection of research reports. To Read Complete Report with Toc: http://www.marketresearchreports.biz/analysis/228987 According to the report, growth in the Non-Small Cell ...